Shenzhen New Henglida Capital Management
Shenzhencnxhld.com
Overview
Shenzhen New Henglida Capital Management is a private equity investment firm based in Shenzhen, China, focusing on venture capital investments in sectors such as hard technology, new energy, new materials, healthcare, and IoT.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Zhejiang Zhongling Technology Co., Ltd. | Jan 2024 | Series B | Co-investor |
| Shenogen Pharma Group | Sep 2023 | Series E Extension | Co-investor |
| Synceres Biosciences | Jun 2023 | Series A Extension | Co-investor |
| Phyplus Technologies | Jun 2022 | D+ Round | Co-investor |
| Wuxi Xinxiang Information Technology Co., Ltd. | Mar 2022 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
